BIM
GCVRZ

BlackRock Investment Management’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

BlackRock Investment Management’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$0 Sell
84
-100
-54% -$34 ﹤0.01% 4061
2016
Q3 		$0 Buy
184
+86
+88% +$22 ﹤0.01% 4124
2016
Q2 		$0 Buy
98
+14
+17% +$2 ﹤0.01% 4293
2016
Q1 		$0 Hold
84
– – ﹤0.01% 4205
2015
Q4 		$0 Hold
84
– – ﹤0.01% 4249
2015
Q3 		$0 Hold
84
– – ﹤0.01% 4265
2015
Q2 		$0 Hold
84
– – ﹤0.01% 4337
2015
Q1 		$0 Hold
84
– – ﹤0.01% 4223
2014
Q4 		$0 Sell
84
-1
-1% -$1 ﹤0.01% 4220
2014
Q3 		$0 Hold
85
– – ﹤0.01% 4153
2014
Q2 		$0 Buy
85
+1
+1% – ﹤0.01% 4177
2014
Q1 		$0 Hold
84
– – ﹤0.01% 3525
2013
Q4 		$0 Hold
84
– – ﹤0.01% 3497
2013
Q3 		$0 Sell
84
-545,490
-100% -$1.04M ﹤0.01% 3449
2013
Q2 		$1.04M Buy
+545,574
New +$958K ﹤0.01% 2330

Other funds holding GCVRZ

SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
MCM
Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
BCM
Brigade Capital Management New York $806M AUM 20.71% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
MFP
Michael F. Price $846M AUM 0.07% 1-Year Est. Return

BlackRock Investment Management's GCVRZ Position: Q4 2016 in Review

BlackRock Investment Management reduced its Sanofi Contingent Value Rights (GCVRZ) stake by 54% in Q4 2016, selling an estimated $34 and leaving 84 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #4061.

BlackRock Investment Management first reported a position in GCVRZ in Q2 2013 and has held it in 15 quarters since. The position peaked at $1.04M in Q2 2013. 120 funds tracked by Wall St. Rank hold GCVRZ as of Q4 2016.

  • BlackRock Investment Management held 84 shares of Sanofi Contingent Value Rights worth $0 as of Q4 2016.
  • BlackRock Investment Management sold 100 Sanofi Contingent Value Rights shares in Q4 2016, an estimated $34.
  • Sanofi Contingent Value Rights made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #4061 holding.
  • BlackRock Investment Management first reported a position in Sanofi Contingent Value Rights in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Investment Management's Sanofi Contingent Value Rights position peaked at $1.04M in Q2 2013.
  • 120 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.